In several cancer types, WEE1, which is the gatekeeper of the G2 arrest, is expressed at high levels, and its inhibition sensitizes cancer cells to DNA-damaging agents by compromising the G2-M checkpoint [166]. This evidence concerns the gene WEE1 and cancer.